Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.455 USD | -3.64% | +0.34% | -23.02% |
04-17 | Rockwell Medical Continues to Expand Its Distribution Capabilities in Western United States | CI |
04-04 | Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda | CI |
Sales 2024 * | 88.97M 7.12B | Sales 2025 * | 101M 8.09B | Capitalization | 42.73M 3.42B |
---|---|---|---|---|---|
Net income 2024 * | -2M -160M | Net income 2025 * | 1M 80.05M | EV / Sales 2024 * | 0.48 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.42 x |
P/E ratio 2024 * |
-14.6
x | P/E ratio 2025 * |
24.3
x | Employees | 237 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97% |
Latest transcript on Rockwell Medical, Inc.
1 day | -3.64% | ||
1 week | +0.34% | ||
Current month | -12.35% | ||
1 month | -11.82% | ||
3 months | +2.46% | ||
6 months | -7.91% | ||
Current year | -23.02% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Strobeck
CEO | Chief Executive Officer | 53 | 30/06/22 |
Jesse Neri
DFI | Director of Finance/CFO | - | 17/10/23 |
Marc Hoffman
CTO | Chief Tech/Sci/R&D Officer | 63 | 19/11/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Cooper
BRD | Director/Board Member | 65 | 06/09/17 |
Allen Nissenson
BRD | Director/Board Member | 77 | 10/06/20 |
Mark Strobeck
CEO | Chief Executive Officer | 53 | 30/06/22 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.455 | -3.64% | 271,004 |
25/04/24 | 1.51 | +1.34% | 210,170 |
24/04/24 | 1.49 | -2.61% | 54,308 |
23/04/24 | 1.53 | +0.99% | 32,305 |
22/04/24 | 1.515 | +4.48% | 136,340 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.02% | 42.73M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- RMTI Stock